Published on
Jul 16, 2025
FDA’s Published CRLs Deliver Insight Into the Drug Approval Process
On July 10, 2025, the FDA published 202 complete response letters (CRLs), many of which were tied to oncology-related drug and biologic product applications (BLAs) submitted within the past decade.1 This marked the first time that the FDA has made many of …
Source:
OncLive
-
Pending
